A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...

The small study, published recently in the journal Obesity, looked at 34 patients who had already lost weight on GLP-1 ...

New research is taking a closer look at what can happen when people stop taking GLP-1 medications for a long period of time.

A newly reported side effect of the popular GLP-1 weight loss drugs may be its most annoying yet. From “Ozempic ears” and “Ozempic butt” to “Ozempic breasts” and “Ozempic face,” people have given many ...

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

Novo Hims strike GLP-1 deal to expand FDA-approved weight loss medication access and end legal dispute over compounded drugs.

Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. But injectable medications aren’t right for everyone. That’s where a new wave of oral GLP-1 ...

Children and teens with type 2 diabetes are more likely to receive insulin than newer GLP-1 receptor agonists, according to a new study published in Pediatrics. Current guidelines from the American ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.